{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:55:14Z","timestamp":1792716914741,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002832","name":"Cl\u00ednica Universidad de Navarra CIMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002832","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jaad.2025.07.060","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:23:01Z","timestamp":1754432581000},"page":"1441-1447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of sequential treatment with cryotherapy followed by 1% topical tirbanibulin for actinic keratoses in organ transplant recipients: A randomized clinical trial"],"prefix":"10.1016","volume":"93","author":[{"given":"Ana","family":"Morell\u00f3-Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Oteiza-Rius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Mar\u00eda","family":"G\u00f3mez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Carrera-Gabilondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deiane","family":"Marcos-Mu\u00f1agorri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Anto\u00f1anzas-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Rodr\u00edguez-Garijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Pilar-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Mar\u00eda","family":"Nu\u00f1ez-C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Salido-Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyre","family":"Aguado-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.07.060_bib1","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13736","article-title":"Skin cancer in transplant recipients: scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe","volume":"33","author":"Stevenson","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jaad.2025.07.060_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bjd.17148","article-title":"Local interventions for actinic keratosis in organ transplant recipients: a systematic review","volume":"180","author":"Heppt","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib4","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1038\/s41598-022-09722-8","article-title":"Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials","volume":"12","author":"Steeb","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaad.2025.07.060_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2340\/00015555-2783","article-title":"Incidence and regression of actinic keratoses in organ transplant recipients","volume":"98","author":"Jiyad","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2025.07.060_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.36849\/JDD.2020.4759","article-title":"Field therapy in solid organ transplant recipients: are we initiating early enough?","volume":"19","author":"Topham","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.07.060_bib8","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3390\/jcm11061654","article-title":"Comparative efficacy and safety of tirbanibulin for actinic keratosis of the face and scalp in Europe: a systematic review and network meta-analysis of randomized controlled trials","volume":"11","author":"Heppt","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2025.07.060_bib9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jamadermatol.2021.3180","article-title":"Consensus-based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a Delphi consensus statement","volume":"157","author":"Massey","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00403-024-02839-y","article-title":"Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy","volume":"316","author":"Patel","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2025.07.060_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ad.2021.07.006","article-title":"Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis","volume":"113","author":"Gilaberte","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2025.07.060_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1056\/NEJMoa2024040","article-title":"Phase 3 trials of tirbanibulin ointment for actinic keratosis","volume":"384","author":"Blauvelt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.07.060_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.36849\/JDD.2020.5576","article-title":"Tirbanibulin ointment 1% as a novel treatment for actinic keratosis: phase 1 and 2 results","volume":"19","author":"Kempers","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib14","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3390\/jcm12144837","article-title":"Tirbanibulin 1% ointment significantly reduces the actinic keratosis area and severity index in patients with actinic keratosis: results from a real-world study","volume":"12","author":"Kirchberger","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2025.07.060_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","article-title":"A new, objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy with ingenol mebutate","volume":"4","author":"Rosen","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2025.07.060_bib16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/jdv.14127","article-title":"Spanish version of the actinic keratosis quality of life questionnaire","volume":"31","author":"Alarcon","year":"2017","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.jaad.2025.07.060_bib17","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/jdv.13626","article-title":"Actinic keratosis: correlation between clinical and histological classification systems","volume":"30","author":"Schmitz","year":"2016","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.jaad.2025.07.060_bib18","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3498","article-title":"Update on the management of cutaneous squamous-cell carcinoma","volume":"100","author":"Maubec","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2025.07.060_bib19","doi-asserted-by":"crossref","DOI":"10.5826\/dpc.1403S1a145S","article-title":"Topical pharmacological treatment of actinic keratoses: focus on tirbanibulin 1% ointment","volume":"14","author":"Valenti","year":"2024","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.jaad.2025.07.060_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40257-023-00839-8","article-title":"Field cancerization therapies for the management of actinic keratosis: an updated review","volume":"25","author":"Aggarwal","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/ajd.14151","article-title":"Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: a prospective study in real clinical practice","volume":"64","author":"Mansilla-Polo","year":"2023","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjd.13222","article-title":"Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients\u2014a randomized controlled trial","volume":"172","author":"Togsverd-Bo","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2133.2006.07616.x","article-title":"Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy","volume":"156","author":"Perrett","year":"2007","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.07.060_bib24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ijd.17168","article-title":"Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients","volume":"63","author":"Nazzaro","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/medicina60020225","article-title":"Tirbanibulin 1% ointment for actinic keratosis: results from a real-life study","volume":"60","author":"Li Pomi","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jaad.2025.07.060_bib26","doi-asserted-by":"crossref","first-page":"T368","DOI":"10.1016\/j.ad.2023.10.045","article-title":"[Translated article] Actinic keratosis in solid organ transplant recipients: a medical literature review","volume":"115","author":"Morell\u00f3 Vicente","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2025.07.060_bib27","first-page":"s4","article-title":"Safety and tolerability of topical agents for actinic keratosis: a systematic review of phase 3 clinical trials","volume":"20","author":"Rajkumar","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.07.060_bib28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ad.2016.03.003","article-title":"Adaptation and validation of the Spanish version of the actinic keratosis quality of life questionnaire","volume":"107","author":"Longo Imedio","year":"2016","journal-title":"Actas Dermosifiliogr"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225025514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225025514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:25:31Z","timestamp":1791879931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225025514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0190962225025514"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.07.060","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of sequential treatment with cryotherapy followed by 1% topical tirbanibulin for actinic keratoses in organ transplant recipients: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}